HomeExpert Team Expert Team

Expert Team

Bringing specialists together to find the most suitable treatment option for every cancer patient.

Expert Team

Bringing specialists together to find the most suitable treatment option for every cancer patient.
Filter Providers By
Expert Team
Filter Providers By
Close
Search for medical departments based on the first letter of pinyin
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z
no data

No relevant content available

Explanatory text explanatory text explanatory text

  • 1
  • 2
  • 3
  • 4
  • 5
Filter Providers By
Search for medical departments based on the first letter of pinyin
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z
  • Wang Jian
    Wang Jian
    Specializes in the comprehensive application of minimally invasive techniques—such as super-selective transarterial chemoembolization (TACE), radioactive seed implantation, physical ablation, and stent placement—to treat both neoplastic and non-neoplastic diseases.
    Profile:
    Fosun Cancer Hospital Guangzhou, Wang Jian, Director and Chief Physician of the Department of Oncology (Ward 5), Guangzhou Fosun Chancheng Hospital. An expert in interventional oncology and interventional radiology, he has performed over 10,000 interventional procedures. He specializes in interventional therapy for solid tumors, including liver, lung, kidney, bladder, gynecological, and head-and-neck cancers, and is proficient in techniques such as transarterial chemoembolization (TACE), radioactive seed implantation, and ablation therapies (microwave, radiofrequency, and argon-helium cryoablation).
  • Cui Zhe
    Cui Zhe
    Specializes in the early diagnosis and minimally invasive comprehensive treatment of various benign and malignant tumors; possesses extensive experience in interventional and multidisciplinary comprehensive treatment for solid tumors, including liver cancer, lung cancer, pancreatic cancer, cholangiocarcinoma, and colorectal cancer with liver metastases.
    Profile:
    Fosun Cancer Hospital Guangzhou, Cui Zhe, Chief Physician of Oncology Ward 5 at Guangzhou Fosun Chancheng Hospital, Chairman of the research team for the "Luo Pengfei Protocol" of tumor diagnosis and treatment, and a renowned physician in the Lingnan region. He specializes in minimally invasive interventional therapy and systemic medical treatment for tumors, with particular expertise in the comprehensive minimally invasive treatment of solid tumors such as primary and metastatic liver cancer, lung cancer, pancreatic cancer, cholangiocarcinoma, and liver metastases from colorectal cancer.
  • Zhou Zhiqiang
    Zhou Zhiqiang
    Specializes in comprehensive minimally invasive interventional therapy for systemic solid malignant tumors, including liver, lung, thyroid, breast, pancreatic, cervical, renal, bladder, and esophageal cancers, as well as gastrointestinal tumors.
    Profile:
    Fosun Cancer Hospital Guangzhou, Zhou Zhiqiang, Associate Chief Physician of Oncology Ward 2 at Guangzhou Fosun Chancheng Hospital. Dedicated to clinical oncology diagnosis and treatment with extensive experience in minimally invasive interventional therapy. Specializes in comprehensive interventional treatment for solid malignant tumors—including liver, lung, thyroid, breast, pancreatic, and cervical cancers, as well as gastrointestinal tumors—and is proficient in techniques such as chemoembolization, ablation, and radioactive seed implantation.
  • Zhang Junjie
    Zhang Junjie
    Specializes in comprehensive minimally invasive interventional therapy for systemic solid malignant tumors, including liver, lung, breast, pancreatic, cervical, renal, bladder, and esophageal cancers, as well as gastrointestinal tumors.
    Profile:
    Fosun Cancer Hospital Guangzhou, Zhang Junjie, Attending Physician of Oncology Ward 3 at Guangzhou Fosun Chancheng Hospital and Head of the MDT Consultation Expert Group for Oncology at Guangzhou Xinshi Hospital. With over 40 years of clinical experience in oncology diagnosis and treatment, he specializes in comprehensive minimally invasive interventional therapy for solid malignant tumors, including liver, lung, breast, pancreatic, cervical, and renal cancers, as well as gastrointestinal tumors.
  • Zhou Zhi
    Zhou Zhi
    Specializes in personalized, comprehensive treatment for malignant tumors at all stages (early, intermediate, and advanced) and standardized cancer pain management; possesses extensive experience in the precision diagnosis and treatment of liver cancer, lung cancer, nasopharyngeal carcinoma, gastric cancer, and colorectal cancer.
    Profile:
    Fosun Cancer Hospital Guangzhou, Zhou Zhi, Attending Physician in Oncology Ward 3 and MDT Expert Consultant at Guangzhou Fosun Chancheng Hospital. With over a decade of clinical experience in oncology, he specializes in personalized and comprehensive treatment for malignant tumors across early, intermediate, and advanced stages. He possesses extensive expertise in the precision diagnosis and treatment of liver, lung, nasopharyngeal, gastric, and colorectal cancers, as well as in minimally invasive interventional oncology, Iodine-125 seed implantation, and hyperthermia therapy.
no data

No relevant content available

Explanatory text explanatory text explanatory text

  • 1
  • 2
  • 3
  • 4
  • 5

Why Choose Us

  • 26,000+
    Over 26,000 international patient visits from 124 countries and regions.
  • 1,000+
    Over 1,000 cancer patients treated with our sixth-generation CyberKnife.
  • 800+
    Over 800 patients treated with the da Vinci Surgical System since April 2023.
  • 500+
    Personalized treatment plans developed for over 500 patients through China–U.S. MDT consultations.

Why Choose Us

  • 26,000+
    Over 26,000 international patient visits from 124 countries and regions.
  • 1,000+
    Over 1,000 cancer patients treated with our sixth-generation CyberKnife.
  • 800+
    Over 800 patients treated with the da Vinci Surgical System since April 2023.
  • 500+
    Personalized treatment plans developed for over 500 patients through China–U.S. MDT consultations.